Pfizer (PFE) Amortization - Intangibles (2009 - 2026)

Pfizer (PFE) has 18 years of Amortization - Intangibles data on file, last reported at $1.2 billion in Q1 2026.

• Quarterly Amortization - Intangibles fell 2.31% year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 billion (down 5.66% YoY) and the FY2025 annual result came in at $4.9 billion, down 7.79% from the prior year.
• Amortization - Intangibles retreated to $1.2 billion in Q1 2026 per PFE's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Amortization - Intangibles topped out at $1.3 billion in Q3 2024 and bottomed at $822.0 million in Q3 2022.
• The 5-year median for Amortization - Intangibles is $1.2 billion (2025), against an average of $1.1 billion.
• The widest annual swing landed in 2022, when Amortization - Intangibles declined 15.08%; it then surged 44.04% in 2023.
• Tracing PFE's Amortization - Intangibles over 5 years: stood at $822.0 million in 2022, then surged by 54.14% to $1.3 billion in 2023, then grew by 3.55% to $1.3 billion in 2024, then retreated by 6.25% to $1.2 billion in 2025, then retreated by 3.82% to $1.2 billion in 2026.
• Per Business Quant, the three latest PFE Amortization - Intangibles figures stand at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025).

Peer Comparison